SCYX - scynexis.com Annual Revenue Growth (Last Twelve Months)

Graphic logo of SCYNEXIS (SCYX)

SCYNEXIS, Inc. (SCYX) generates revenue through the sale of innovative antimycotics and licensing fees from its therapeutic platform. The revenue trend over four quarters year-over-year reflects demand dynamics, where 542.90 indicates the current level. Supply stability is guaranteed by the operational efficiency of contractor capacities, although risks of disruptions in Asian raw materials and the complexities of global testing create a certain geopolitical vulnerability.

scynexis.com (SCYX) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/15/2026

Summary analytical data breakdowns for scynexis.com (SCYX)

- current price and projected stock value:
Price Scynexis|SCYX - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization SCYNEXIS Inc|SCYX - Total Company Value
- balance sheet equity data:
Net Asset Value per Share SCYNEXIS|SCYX - Company Book Value|Capitalization to Book Value Ratio scynexis.com|SCYX - Aggregate Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Coefficient SCYNEXIS, Inc.|SCYX - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Scynexis|SCYX - Company Aggregate Debts|Debt to Book Value Scynexis|SCYX - Company Long-Term Liabilities|Short-Term Debt SCYNEXIS|Immediate Liquidity Ratio scynexis.com
- earnings and market multiples details:
SCYX - Net Profit|Expected Net Profit SCYNEXIS, Inc.|SCYX - Price to Earnings Ratio|Price to Future Earnings Ratio Scynexis|SCYX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio SCYNEXIS Inc|SCYX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters SCYNEXIS|SCYX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months scynexis.com|SCYX - Earnings growth in current year|Consensus forecast of earnings per share growth for next year SCYNEXIS, Inc.
- sales and revenue data:
SCYX - Company Revenue|Company Revenue Forecast Scynexis|SCYX - P/S Multiple|Forward Price-to-Revenue Multiple Scynexis|SCYX - Revenue Growth YoY (Last 12 Months)
Summary company analytics:SCYX - SCYNEXIS Inc
Signature product of SCYNEXIS, Inc.

SCYNEXIS, Inc. (SCYX) operates in an isolated biotechnology segment where demand for drugs remains independent of macroeconomic fluctuations. The current year-over-year sales trend over 12 months illustrates the dynamics of this resilience. This metric measures daily revenue growth over a rolling year, excluding seasonality. It is critical for investors to monitor the business's ability to exercise pricing power without triggering customer churn. Stable growth confirms the quality of the company's fundamental assets.

Competitor analysis for SCYNEXIS, Inc.

Revenue Change YoY (Last 12 Months) SMMT (Summit Therapeutics Inc)|modernatx.com - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) vaxcyte.com PCVX|Tarsus Corp (TARS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth CorMedix Inc (CRMD)|Sales Growth YoY (Last Twelve Months) Seres Therapeutics|Sales Growth YoY (Last 12 Months) SPRO (Spero Pharma)|Sales Growth YoY (Last Twelve Months) AN2 Bio (ANTX)|Annual Revenue Growth (Last Twelve Months) PolyPid Ltd|Sales Growth YoY (TTM) LSB (ysbiopharm.com)|Annual Revenue Growth (Last Twelve Months) iterumtx.com (ITRM)|BiomX Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Soligenix|SXTP: Sales Growth YoY (TTM)|Oragenics, Inc. (OGEN) - Sales Growth YoY (TTM)|OPGN (OpGen Corporation) - Sales Growth YoY (TTM)